Celldex Therapeutics | CLDX - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Agenus USD 137K 19K 2025-03
Amgen USD 1.79B 128M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Glaxosmithkline GBP 3.01B 853.01M 2025-09
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pfizer USD 6.29B 2.12B 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 8.48B 4.61B 2025-12